Shawn O’Brien Acquires 326,452 Shares of Mayne Pharma Group (ASX:MYX) Stock

Mayne Pharma Group Limited (ASX:MYX) insider Shawn O’Brien bought 326,452 shares of the company’s stock in a transaction that occurred on Thursday, December 18th. The stock was bought at an average cost of A$3.03 per share, for a total transaction of A$989,149.56.

Shawn O’Brien also recently made the following trade(s):

• On Thursday, December 18th, Shawn O’Brien sold 129,736 shares of Mayne Pharma Group stock. The stock was sold at an average price of A$3.09, for a total transaction of A$401,403.18.

Mayne Pharma Group Price Performance

The company has a debt-to-equity ratio of 8.55, a quick ratio of 0.62 and a current ratio of 1.47. The stock has a market cap of $446.85 million, a price-to-earnings ratio of -2.56, a price-to-earnings-growth ratio of 0.51 and a beta of 1.24.

About Mayne Pharma Group

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women’s health, and infectious disease therapeutic areas.